-
CB-839 (Telaglenastat) in Cancer Metabolism
2026-09-05
CB-839 (Telaglenastat) gives researchers a direct, reversible way to test whether glutaminase 1 dependence drives tumor-cell fitness, apoptosis, or autophagy. This workflow connects glutaminolysis inhibition assays with the spliceosomal and epitranscriptomic vulnerabilities reported in MYCN-amplified neuroblastoma.
-
Endogenous H2S Deficiency in Diabetic Cardiomyopathy
2026-09-05
The reference study identifies reduced endogenous hydrogen sulfide production as a mechanistic contributor to lipid-induced myocardial injury in diabetic cardiomyopathy. Using patient samples, diabetic rats, and palmitate-treated cardiomyocytes, it links H2S deficiency with endoplasmic reticulum stress and shows that H2S donation or ER-stress inhibition reduces cardiac lipotoxicity.
-
Zolmitriptan Workflows for 5-HT1B Research
2026-09-04
Build reproducible receptor-signaling, vascular, and neuropeptide assays with Zolmitriptan, a selective serotonin ligand for migraine and cluster headache research. This guide combines solvent handling, subtype-resolved experimental design, orthogonal controls, and lysosome-inspired workflow logic without overstating evidence across disease domains.
-
Macrophage–Adipoq+ Signaling in S. aureus Osteomyelitis
2026-09-04
A 2025 Nature Communications study identifies a host stromal mechanism that helps Staphylococcus aureus abscesses persist in bone marrow: macrophage-derived amphiregulin drives Adipoq+ marrow precursors toward a perfusion-limiting myofibroblast state. Genetic and pharmacological disruption of the AREG–EGFR–mTOR–YAP axis reduced fibrosis, improved antibiotic delivery, and enhanced bacterial clearance in a mouse osteomyelitis model.
-
miR-196a Drives EAC Through the MYC/TERT/NFκB Axis
2026-09-03
The reference study moves beyond biomarker association by showing that miR-196a can actively promote an aggressive esophageal adenocarcinoma phenotype through coordinated MYC, TERT, and NFκB signaling. Its combination of cell-based perturbation, mechanistic rescue experiments, and Barrett’s esophagus tissue analysis identifies a testable pathway linking disease progression with epithelial-to-mesenchymal transition and cell motility.
-
HyperScript RT SuperMix for qPCR in NSCLC
2026-09-03
Apply a high-temperature, mixed-primer reverse transcription workflow to quantify SPI1 and related transcripts in NSCLC models, including low-input RNA samples. The protocol also clarifies when mature miRNA targets such as miR-616-5p require a dedicated small-RNA assay rather than conventional cDNA synthesis alone.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-02
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines innate immune challenges with targeted metabolic perturbations and cytokine measurement. The workflow preserves the multicellular context of blood while improving comparability across donors and cohorts, making it useful for studying how anabolic and catabolic pathways shape immune function.
-
2-NBDG Glucose Uptake Assay Kit for HCC Metabolism
2026-09-02
The 2-NBDG Glucose Uptake Assay Kit provides a rapid, non-radioactive way to connect transporter activity with therapy-response phenotypes in hepatocellular carcinoma models. Its 96-well format, single-cell compatibility, and phloretin specificity control make it useful for screening sorafenib-resistant cells, organoids, and metabolic interventions.
-
BIBR 1532 Telomerase Inhibitor Workflows
2026-09-01
BIBR 1532 enables mechanism-focused studies that connect hTERT inhibition with cancer cell proliferation, transcriptional responses, and apoptosis. This practical guide shows how to build robust telomerase activity assay workflows, compare telomere-targeting strategies, and troubleshoot short-term versus long-term readouts.
-
Light-Inducible RNA Switches for Gene Therapy
2026-08-31
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at the translational level. In mouse models, LIRP enabled light-responsive treatment of diet-induced obesity and retinal neovascular disease, illustrating how reversible optogenetic control could improve the timing and safety of gene therapy.
-
Cefepime (BMY-28142) in Resistance-Aware Assays
2026-08-31
Cefepime (BMY-28142) offers a research framework for connecting broad-spectrum antibacterial activity, CNS exposure, and resistance phenotyping. This article explains how time-resolved assays and adaptive-resistance modeling can improve bacterial infection model design.
-
Hepatocyte Arrb2 and 6-ketoLCA in Liver IRI
2026-08-30
This study identifies hepatocyte β-arrestin 2, encoded by Arrb2, as an immunometabolic regulator of hepatic ischemia–reperfusion injury. By connecting hepatocyte Arrb2 with increased 6-ketoLCA and M2 macrophage polarization, the work provides a mechanistic framework for studying liver injury resolution and transplantation outcomes.
-
KN-62 for CaMKII and Calcium Signaling Workflows
2026-08-29
KN-62 provides a selective way to test whether CaMKII links calcium signals to secretion, glucose handling, or cell-cycle behavior. This practical guide combines dose planning, orthogonal calcium assays, and troubleshooting to separate kinase-dependent effects from upstream channel pharmacology.
-
CHI3L1-IN-5: A Translational Route to Astrocyte Repair
2026-08-29
CHI3L1-IN-5, also known as Compound Z17, connects selective CHI3L1 inhibition with CNS exposure, NF-κB pathway modulation, astrocyte Aβ uptake restoration, and lysosomal function repair. This thought-leadership guide places the compound in a translational framework while distinguishing product-specific evidence from broader medicinal-chemistry lessons.
-
Central Control of Opioid Mechanical Hypersensitivity
2026-08-28
Yin et al. identify a brain-to-spinal opioid pathway linking lateral parabrachial MOR neurons, hypothalamic dynorphin neurons, and spinal KOR-expressing GABAergic neurons to morphine-induced mechanical hypersensitivity and tolerance. The study shows that local MOR activation can paradoxically worsen mechanical pain and that circuit-level interventions can rescue these effects in mice, providing a framework for more precise pain mechanism research.